USD 0.0
(-10.0%)
Breakdown | 2014 | 2013 | 2012 | 2011 |
---|---|---|---|---|
Operating Cash Flow | -588.97 Thousand | -307.33 Thousand | -40.58 Thousand | -5500.00 |
Net Income | -3.33 Million | -462.08 Thousand | -41.09 Thousand | - |
Depreciation & Amortization | 277.00 | 215.00 | - | - |
Deferred income taxes | - | - | - | - |
Stock-based compensation | 1.4 Million | 78.2 Thousand | - | - |
Change in working capital | 528.17 Thousand | 221.24 Thousand | 515.00 | 2115.00 |
Other non-cash items | 2.21 Million | -66.71 Thousand | - | -7615.00 |
Investing Cash Flow | - | -24.85 Thousand | - | - |
Investments in PPE | - | -2152.00 | - | - |
Acquisitions | - | - | - | - |
Investment purchases | - | - | - | - |
Sales/Maturities of investments | - | - | - | - |
Other Investing Activities | - | -22.7 Thousand | - | - |
Financing Cash Flow | 563.69 Thousand | 347.25 Thousand | 40.92 Thousand | 5500.00 |
Debt repayment | -441.27 Thousand | -44.5 Thousand | - | - |
Dividends payments | - | - | - | - |
Common Stock Repurchased | - | - | - | - |
Common Stock Issuance | - | - | 38.5 Thousand | 5000.00 |
Other Financing Activities | 1 Million | 391.75 Thousand | 2425.00 | 500.00 |
Accounts receivables | - | - | - | - |
Accounts payables | 132.5 Thousand | 144.3 Thousand | 515.00 | 2115.00 |
Inventory | - | - | - | - |
Other working capital | 395.66 Thousand | 76.94 Thousand | - | - |
Cash at beginning of period | 34.9 Thousand | 19.84 Thousand | - | - |
Cash at end of period | 10.6 Thousand | 34.9 Thousand | 342.00 | - |
Capital Expenditure | - | -2152.00 | - | - |
Effect of forex changes on cash | 974.00 | - | - | - |
Net cash flow / Change in cash | -24.3 Thousand | 15.06 Thousand | 342.00 | - |
Free Cash Flow | -588.97 Thousand | -309.48 Thousand | -40.58 Thousand | -5500.00 |
Breakdown | 2021 Q3 | 2020 Q3 | 2015 Q3 | 2015 Q2 | 2015 Q1 | 2014 FY |
---|---|---|---|---|---|---|
Operating Cash Flow | - | - | - | - | - | - |
Net Income | -45.51 Thousand | -39.13 Thousand | -223.46 Million | -562.43 Thousand | -368.04 Thousand | -3.33 Million |
Depreciation & Amortization | - | - | 77.00 | 77.00 | 76.00 | 277.00 |
Deferred income taxes | - | - | - | - | - | - |
Stock-based compensation | - | - | - | 46.00 | 1800.00 | 1.4 Million |
Change in working capital | - | - | 174.99 Thousand | 123.92 Thousand | 177.33 Thousand | 528.17 Thousand |
Other non-cash items | 45.51 Thousand | 39.13 Thousand | 223.25 Million | 382.72 Thousand | 180.05 Thousand | 2.21 Million |
Investing Cash Flow | - | - | - | - | - | - |
Investments in PPE | - | - | - | - | - | - |
Acquisitions | - | - | - | - | - | - |
Investment purchases | - | - | - | - | - | - |
Sales/Maturities of investments | - | - | - | - | - | - |
Other Investing Activities | - | - | - | - | - | - |
Financing Cash Flow | - | - | 38.5 Thousand | 57.85 Thousand | - | 563.69 Thousand |
Debt repayment | - | - | - | - | - | -441.27 Thousand |
Dividends payments | - | - | - | - | - | - |
Common Stock Repurchased | - | - | - | - | - | - |
Common Stock Issuance | - | - | - | - | - | - |
Other Financing Activities | - | - | 38.5 Thousand | 57.85 Thousand | - | 1 Million |
Accounts receivables | - | - | - | - | - | - |
Accounts payables | - | - | 23.81 Thousand | -19.86 Thousand | 3418.00 | 132.5 Thousand |
Inventory | - | - | - | - | - | - |
Other working capital | - | - | 151.18 Thousand | 143.78 Thousand | 173.91 Thousand | 395.66 Thousand |
Cash at beginning of period | - | - | 2151.00 | 11.00 | 10.6 Thousand | 34.9 Thousand |
Cash at end of period | - | - | 343.00 | 2151.00 | 11.00 | 10.6 Thousand |
Capital Expenditure | - | - | - | - | - | - |
Effect of forex changes on cash | - | - | - | - | -9.00 | 974.00 |
Net cash flow / Change in cash | - | - | -1808.00 | 2140.00 | -10.59 Thousand | -24.3 Thousand |
Free Cash Flow | - | - | -40.3 Thousand | -55.71 Thousand | -10.58 Thousand | -588.97 Thousand |
CSTAF
ISOLF
SBCF
BIOCQ
ASND
002199